Bio-Techne (TECH) Operating Expenses (2009 - 2026)

Bio-Techne's Operating Expenses history runs 18 years deep, the most recent figure standing at $132.8 million for Q1 2026.

• In Q1 2026, Operating Expenses fell 24.48% year-over-year to $132.8 million; the TTM figure through Mar 2026 stood at $632.7 million (up 1.58% YoY), while the FY2025 annual figure was $688.0 million, up 22.2% from the prior year.
• Operating Expenses for Q1 2026 stood at $132.8 million, down from $136.8 million in the prior quarter.
• The five-year high for Operating Expenses was $222.7 million in Q2 2025, with the low at $110.2 million in Q2 2023.
• The 5-year median for Operating Expenses is $136.8 million (2025), against an average of $139.0 million.
• The sharpest annual moves came in 2024 and 2026: Operating Expenses soared 42.98% in 2024, then dropped 24.48% in 2026.
• Bio-Techne's Operating Expenses stood at $115.5 million in 2022, then gained by 20.02% to $138.6 million in 2023, then climbed by 5.69% to $146.5 million in 2024, then slipped by 6.59% to $136.8 million in 2025, then fell by 2.94% to $132.8 million in 2026.
• Business Quant data shows TECH's Operating Expenses at $132.8 million in Q1 2026, $136.8 million in Q4 2025, and $140.5 million in Q3 2025.